Gubra AS (CHIX:GUBRAC) Short Interest


CHIX:GUBRAC Gubra AS CHIX:GUBRAC
73 GF Score
Price kr354.50
GF Value kr2,972.88
! 3 Warning Signs
View Full Analysis

What is Gubra AS Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

CHIX:GUBRAC vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, Gubra AS's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gubra AS Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gubra AS's Short Interest distribution charts can be found below:

* The bar in red indicates where Gubra AS's Short Interest falls into.


CHIX:GUBRAC
73GF Score
Gubra AS CHIX:GUBRAC
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Gubra AS (CHIX:GUBRAC) Overvalued in 2026?

Based on GuruFocus' analysis, Gubra AS stock appears to be undervalued. The current stock price of kr354.50 is trading 88.1% below its estimated GF Value™ of kr2,972.88.

Key valuation signals for CHIX:GUBRAC:

  • Short Interest:
  • GF Value™: kr2,972.88 vs. price of kr354.50 (88.1% below fair value)
  • GF Score™: 73/100 with 3 warning signs

No single metric tells the full story. See the CHIX:GUBRAC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Gubra AS Business Description

Other Exchanges GUBRA:DenmarkPI3:Germany
Address Horsholm Kongevej 11B, Horsholm, DNK, 2970
Gubra AS is a specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases. The company has two segments: Pre-clinical contract research (CRO), which derives maximum revenue and Biotech Segment. It derives maximum revenue from Pre-clinical contract research (CRO) segment. Geographically, the company operates in Europe, North America and Other regions.
73GF Score

Get the complete analysis for CHIX:GUBRAC

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr354.50
Price
kr2,972.88
GF Value